Notice to Vermont Prescribers
Vermont’s Pharmaceutical Marketer Price Disclosure Law (18 V.S.A. § 4633) requires pharmaceutical marketers to disclose to Vermont doctors and prescribers the average wholesale price (AWP) per pill of any drugs they market in Vermont as well as the AWP per pill of other drugs in the same therapeutic class.
|Product Name||Short Form||Long Form|
|Oxbryta® (voxelotor) tablets|
Oxbryta® (voxelotor) tablets for oral suspension
|Oxbryta Short Form||Oxbryta Long Form|
Guide to Vermont’s Pharmaceutical Marketer Price Disclosure Law, 33 V.S.A. § 2005a. Published by the Vermont Office of the Attorney General.
Please see Full Prescribing Information for Oxbryta.